• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Professional Introduction to 3-Bromopyridine-2-carboxylic acid (CAS No. 30683-23-9)

3-Bromopyridine-2-carboxylic acid, identified by the chemical abstracts service number 30683-23-9, is a significant intermediate in modern pharmaceutical and chemical synthesis. This compound, featuring a brominated pyridine core with a carboxylic acid functional group, has garnered considerable attention due to its versatile applications in medicinal chemistry and material science. The unique structural attributes of 3-bromopyridine-2-carboxylic acid make it a valuable building block for the development of novel bioactive molecules, particularly in the synthesis of targeted therapeutics and functional materials.

The utility of 3-bromopyridine-2-carboxylic acid stems from its reactivity at both the bromine substituent and the carboxylic acid moiety. The bromine atom provides a handle for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings, enabling the construction of complex heterocyclic frameworks. Concurrently, the carboxylic acid group allows for derivatization into esters, amides, or anhydrides, broadening its synthetic applicability. These features have positioned 3-bromopyridine-2-carboxylic acid as a cornerstone in the synthesis of small-molecule drugs and advanced materials.

In recent years, advancements in drug discovery have highlighted the importance of pyridine derivatives in medicinal chemistry. 3-Bromopyridine-2-carboxylic acid has been extensively employed in the development of kinase inhibitors, antiviral agents, and anti-inflammatory compounds. For instance, researchers have leveraged its scaffold to design molecules targeting diseases such as cancer and neurodegenerative disorders. The bromine atom serves as a critical site for introducing diversity through transition-metal-catalyzed reactions, while the carboxylic acid group facilitates further conjugation with biomolecules or other pharmacophores.

One notable application of 3-bromopyridine-2-carboxylic acid is in the synthesis of protease inhibitors. Proteases play pivotal roles in various biological pathways, making them attractive targets for therapeutic intervention. By incorporating 3-bromopyridine-2-carboxylic acid into peptidomimetic scaffolds or non-peptide inhibitors, chemists have been able to develop potent and selective protease inhibitors with improved pharmacokinetic profiles. The ability to modify both the bromine and carboxylate positions allows for fine-tuning of binding interactions with target enzymes, enhancing drug efficacy.

The compound has also found relevance in materials science, particularly in the design of organic electronic materials. Pyridine-based polymers and small molecules exhibit desirable electronic properties such as high charge carrier mobility and thermal stability. Functionalization of these materials with groups like 3-bromopyridine-2-carboxylic acid can modulate their electronic characteristics, making them suitable for applications in organic light-emitting diodes (OLEDs), field-effect transistors (OFETs), and photovoltaic devices. The bromine atom provides a site for polymerization or further cross-linking reactions, while the carboxylic acid group can enhance solubility or compatibility with other functional materials.

Recent studies have explored the use of 3-bromopyridine-2-carboxylic acid in flow chemistry applications, which offer advantages such as scalability, reproducibility, and energy efficiency. Flow chemistry enables controlled reaction conditions and rapid product isolation, making it an attractive approach for large-scale synthesis. By integrating 3-bromopyridine-2-carboxylic acid into continuous-flow processes, researchers have achieved high yields and purity levels while minimizing waste generation. This aligns with the growing emphasis on sustainable chemical synthesis in pharmaceutical manufacturing.

The versatility of 3-bromopyridine-2-carboxylic acid is further underscored by its role in fragment-based drug discovery (FBDD). Fragment-based approaches involve screening small molecular libraries to identify lead compounds that bind to biological targets. 3-Bromopyridine-2-carboxylic acid, with its well-defined reactivity patterns, serves as a key fragment that can be linked to other pharmacophores through iterative optimization cycles. This strategy has proven effective in identifying novel drug candidates with improved binding affinity and selectivity.

In conclusion,3-Bromopyridine-2-carboxylic acid (CAS No. 30683-23-9) represents a pivotal intermediate with far-reaching implications in pharmaceutical research and material science. Its dual functionality at the bromine and carboxylate positions enables diverse synthetic pathways, facilitating the development of innovative therapeutics and advanced materials. As research continues to uncover new applications for this compound,3-bromopyridine-2-carboxylic acid is poised to remain a cornerstone of modern chemical synthesis.

• 53636-56-9(methyl 3-bromopyridine-2-carboxylate)
• 61830-12-4(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-)
• 61830-40-8(3,5-Dibromopicolinic acid)
• 1189933-55-8(3-Bromopicolinic Acid Sodium Salt)
• 61830-10-2(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-, dimethyl ester)
• 316808-11-4(Dimethyl 3-bromopyridine-2,6-dicarboxylate)
• 779344-30-8(3-bromo-6-methylpyridine-2-carboxylic acid)
• 30766-11-1(5-bromopyridine-2-carboxylic acid)
• 61830-41-9(2-Pyridinecarboxylic acid, 3,5-dibromo-, methyl ester)
• 316808-10-3(3-Bromopyridine-2,6-dicarboxylic acid)